CIBC Asset Management
RVMD icon

CIBC Asset Management’s Revolution Medicines RVMD Stock Holding History

CIBC Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$805K Buy
8,276
+2,238
+37% +$226K ﹤0.01% 725
2025
Q4 		$481K Buy
6,038
+917
+18% +$60.1K ﹤0.01% 810
2025
Q3 		$239K Buy
+5,121
New +$201K ﹤0.01% 1054
2025
Q1 		– Sell
-5,037
Closed -$220K – 1234
2024
Q4 		$220K Buy
5,037
+270
+6% +$13.6K ﹤0.01% 1064
2024
Q3 		$216K Buy
+4,767
New +$208K ﹤0.01% 1061

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIBC Asset Management's RVMD Position: Q1 2026 in Review

CIBC Asset Management increased its Revolution Medicines (RVMD) stake by 37% in Q1 2026, buying an estimated $226K and bringing the position to 8,276 shares worth $805K. The position accounts for ﹤0.01% of the portfolio, ranked #725.

CIBC Asset Management first reported a position in RVMD in Q3 2024 and has held it in 5 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • CIBC Asset Management held 8,276 shares of Revolution Medicines worth $805K as of Q1 2026.
  • CIBC Asset Management bought 2,238 Revolution Medicines shares in Q1 2026, an estimated $226K.
  • Revolution Medicines made up ﹤0.01% of CIBC Asset Management's portfolio in Q1 2026, its #725 holding.
  • CIBC Asset Management first reported a position in Revolution Medicines in Q3 2024 and has held it in 5 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.